Clinical Trial Update: Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing azathioprine to mesalazine for preventing postoperative recurrence in Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Azathioprine (azathioprine)
• Mesalazine (mesalazine)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED